AMSBIO's comprehensive portfolio of knock-out cell lines and lysates

AMSBIO has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology.

Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function.

Knock-out cell lines and cell lysates are widely agreed to be the best negative controls to quickly and confidently prove an antibody’s specificity for a target of interest and ensure reproducibility.

Generated in the most widely used HEK293T, HeLa, and A549 cell lines, AMSBIO gene edited homozygous knock-out cell lines work in the cells you know and trust.

Consequently, you are no longer limited to highly specialized and altered backgrounds. AMSBIO offers only 100% knock-out clonal lines meaning you don't have to work with pools of cells containing only a percentage of knockout cells.

Knock-out cell lysates from AMSBIO are made from double knock-out cell lines and provide the perfect negative control for Western Blots to validate the specificity of antibodies or be used in functional assays. Each AMSBIO knock-out cell lysate product comes with a cell-line matched wild type control.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Biotechnology. (2019, February 14). AMSBIO's comprehensive portfolio of knock-out cell lines and lysates. News-Medical. Retrieved on May 22, 2019 from https://www.news-medical.net/news/20190214/AMSBIOs-comprehensive-portfolio-of-knock-out-cell-lines-and-lysates.aspx.

  • MLA

    AMS Biotechnology. "AMSBIO's comprehensive portfolio of knock-out cell lines and lysates". News-Medical. 22 May 2019. <https://www.news-medical.net/news/20190214/AMSBIOs-comprehensive-portfolio-of-knock-out-cell-lines-and-lysates.aspx>.

  • Chicago

    AMS Biotechnology. "AMSBIO's comprehensive portfolio of knock-out cell lines and lysates". News-Medical. https://www.news-medical.net/news/20190214/AMSBIOs-comprehensive-portfolio-of-knock-out-cell-lines-and-lysates.aspx. (accessed May 22, 2019).

  • Harvard

    AMS Biotechnology. 2019. AMSBIO's comprehensive portfolio of knock-out cell lines and lysates. News-Medical, viewed 22 May 2019, https://www.news-medical.net/news/20190214/AMSBIOs-comprehensive-portfolio-of-knock-out-cell-lines-and-lysates.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
AMSBIO's Detachin provides rapid and efficient cell detachment